Joseph Todisco

Joseph Todisco, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in CorMedix Inc., Amneal Pharmaceuticals, Inc. and Talphera, Inc. Over a trading history stretching from 7 May 2021 to 4 February 2026, the count stands at 26 filings.

In open-market terms, that means 6 purchases worth €227k on one side and 1 sale worth €5,433 on the other. Purchases outweigh sales by €222k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 12 share grants and 7 option exercises.

Half of the purchases are above €34k and half below. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 6 February 2026 came the latest disclosure, a share grant in CorMedix Inc. The last insider purchase was made public on 14 March 2024, 948 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.